Lead Product(s) : mRNA Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Sanofi
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs in real-world pharmaceutical practice beyond Covid-19.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
November 22, 2021
Lead Product(s) : mRNA Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Sanofi
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Lead Product(s) : Synthetic Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Boehringer Ingelheim GmbH
Deal Size : $14.0 million
Deal Type : Financing
Details : The financing will be used to accelerate the building of synthetic biology vaccine platforms and advance pipelines of synthetic vaccines to clinical trials.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
November 03, 2021
Lead Product(s) : Synthetic Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Boehringer Ingelheim GmbH
Deal Size : $14.0 million
Deal Type : Financing
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Johnson & Johnson Innovative Medicine
Deal Size : Undisclosed
Deal Type : Collaboration
Details : As part of the agreement, the parties plan to utilize a multitargeting drug conjugation platform developed by TenNor to discover new therapies for the treatment of nontuberculous mycobacteria (NTM) diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 21, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Johnson & Johnson Innovative Medicine
Deal Size : Undisclosed
Deal Type : Collaboration